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 Introduction 
Genetic association  
The growth of psychiatric genetics has heralded in a new era of knowledge about psychiatric 
and neurodevelopmental disorders. Genome-wide association studies (GWAS) have been 
highly influential in identifying common variation in genes that are over or underrepresented 
in individuals with a certain disorder. These studies identify single-nucleotide 
polymorphisms(SNPs) that occur throughout the genome that increase risk for 
neuropsychiatric disorders. One of the first, and now well replicated, GWAS finding in 
psychiatry was the association of SNP rs1006737 within the calcium voltage-gated channel 
subunit alpha1c (CACNA1C) gene with bipolar disorder1. This association was confirmed in 
a larger data set2, and subsequent studies showed a further association of this SNP with 
schizophrenia, major depressive disorder (MDD) and autism (Table 1). Further SNPs within 
CACNA1C have since been associated with these disorders in multiple studies (Table 1).   
 The majority of these SNPs are in known linkage disequilibrium with each other, except 
rs7297582 and rs12898315, potentially due to the fact they are less studied. The SNPs lie 
within introns, within predicted enhancers which can interact with the CACNA1C 
transcription start site25 and therefore may determine gene expression26,27. rs1006737 has 
been shown to be an expression quantitive trait loci (eQTL) for CACNA1C expression: 
associated with decreased expression27.  
CACNA1C SNPs were found to have shared effects across attention deficit hyperactivity 
disorder (ADHD), autism, BPD, SCZ and major depressive disorder22, implying that common 
variation in CACNA1C may be associated with particular symptom clusters instead of one 
particular disorder.  
In addition to GWAS findings, large exome sequencing studies have shown that rare 
disruptive mutations within calcium ion channels are enriched in patients with 
schizophrenia28 and autism29,30. Furthermore, missense mutations in exon 8, or the 
alternatively spliced exon 8a, of CACNA1C can cause an autosomal dominant genetic 
disorder named Timothy Syndrome (TS)31. TS is a multisystem channelopathy characterised 
by cardiac defects, craniofacial abnormalities, autism and cognitive impairments. There are 
two common types of Timothy Syndrome characterised by mutation; TS1 (G406R in exon 
8a) and the more severe form TS2 (G406R or G402S in exon 8). Both TS1 and TS2 are 
characterised by gain-of-function mutations in CACNA1C 32.  
Cacna1c, gene transcription and synaptic plasticity  
CACNA1C encodes for the alpha1c subunit of the Cav1.2 L-type voltage-gated calcium 
channel (LTCC). This subunit forms the pore through which calcium influxes into a cell and 
initiates downstream signalling cascades33. LTCCs have a prominent role in controlling gene 
expression through coupling membrane depolarisation with cAMP response element-binding 
protein (CREB) phosphorylation via local Ca2+/calmodulin-dependent protein kinase II 
(CaMKII) signalling34. CREB can bind to a critical Ca2+ response element within brain derived 
neurotrophic factor (BDNF) to trigger its transcription35,36. This pathway, and particularly 
CREB and BDNF, are thought to be essential for learning and memory processes. Synaptic 
plasticity, which is thought to underlie learning and memory, can be modulated by 
LTCCs37,38; LTCC antagonists reduce induction of long-term potentiation (LTP) in the CA1 of 
the rat hippocampus39. Cav1.2 knockdown models have shown reduced CREB transcription 
and hippocampal LTP40,41, implicating the important of these channels in gene expression 
and plasticity.  
This review aims to give a brief overview of the current phenotypes relevant to psychiatric 
and neurodevelopmental disorders studied so far in animal models of Cacna1c/Cav1.2 
dysfunction, including new findings on impacts on neurogenesis in a rat model of reduced 
gene dosage of Cacna1c.  
Models  
Genetic Cacna1c/Cav1.2 rodent models have mostly concentrated on reduced gene dosage. 
Some studies utilise a constitutive heterozygote model (Cacna1c+/-) to study gene dosage 
effects as the homozygote model is embryonically lethal. However other studies have 
utilised region-specific complete knockouts of Cacna1c (Cacna1c-/-) driven by specific 
promotors to disentangle the neuronal contribution of this gene compared to the cardiac 
properties. Bader and colleagues (2011) developed a genetic mouse model based on TS242. 
While both homozygote and heterozygote knockout of exon 8a were lethal, a heterozygote 
model that included an inverted neonmycin cassette was viable (TS2_neo)42. An overview of 
the genetic Cacna1c/Cav1.2 mouse models and their associated phenotypes are presented 
in Table 2.  
 
 
Motor function 
Neurodevelopmental disorders, particularly autism, can present with neurological 
disturbance of the motor system resulting in abnormal gait 54,55 and dysfunctions in 
movement planning and execution56. Bader et al (2011) reported that TS2_neo mice had 
similar motor abilities and reflexes in their home cage, however had decreased locomotion 
when placed in a novel environment42. Consistently, another study reported that whilst 
TS2_neo mice had no deformities in gait, they had reduced locomotion in social tests such 
as reciprocal social interaction, urine open field test and increased freezing in the Smartcube 
platform challenge43. Cacna1c+/- mice were reported to be markedly hypoactive in both a 
home cage and novel environment42, however studies on Cacna1c+/- mice using a rotarod 
paradigm40,44,48  did not report any differences in motor ability or co-ordination. A prefrontal 
cortex specific elimination of Cacna1c also did not result in any different basal locomotor 
behaviour49. Dao et al (2010) also reported no genotype differences in motor activity in the 
home cage however did report a slight hypoactivity in females in the open field test, as well 
as reduced exploratory activity in the holeboard test44. 
The role of Cav1.2 in motor activity thus requires further clarification, models suggest that 
dysfunction in Cacna1c may lead to elements of hypoactivity. It is important to consider that 
this reduced locomotion could in part reflect an indication of anxiety in contrast to a motor 
deficit per se.  
Sociability  
Social interactions, and the perceptions of them, are often altered in psychiatric patients. 
TS2_neo mice show no sociability defects in the 3 chamber test43 and maintained social 
memory42, however present decreased activity in social interactions. They also initiate less 
social events, but maintain them longer42,43. The Cacna1c+/- knock out mouse did not show 
any differences in social beahviour42, however a Cacna1c+/- excitatory neuron knockout 
showed decreased sociality53. This suggests that some subtle elements of social interactions 
may be affected in Cav1.2 dysfunction, but no global social deficits are present.  
Fear conditioning 
Aversive associative learning processes such as fear conditioning can be used to investigate 
learning, memory and cognitive processes in animal models. They can give us an 
understanding on the neural circuity that is affected in a wide range of psychiatric disorders. 
Interestingly it has been shown that Cav1.2 levels are increased in the amygdala following 
fear conditioning57. In genetic models, deletion of Cav1.2 in the anterior cingulate cortex 
results in decreased observational fear learning, where unconditioned mice develop freezing 
behaviour by observing conditioned mice receiving foot shocks58. TS2-neo mice can acquire 
cued fear conditioning correctly, however demonstrate increased freezing in context and cue 
recalls, as well as reduced extinction42. The authors suggest that this is due to an enhanced 
perseverance of both tone and context memory. However, other models of Cacna1c 
knockdown do not show alterations of fear memory. Animals with neuron specific knockout 
of Cacan1c-/- show no impairments in acquisition, consolidation or recall of auditory48 or 
contextual50 fear conditioning paradigms. However, Temme et al (2016) did show significant 
context discrimination deficits in their neuronal knockout model50. The Cacna1c-/- (forebrain 
excitatory neurons only) model also maintained successful consolidation and extinction of 
conditioned fear46. This disparity between the Cacna1c knockdown models and TS models is 
interesting and may suggest that there are some compensatory adaptations48. Future 
studies on Cacna1c+/- models would be beneficial to further investigate Cav1.2’s  influence 
over fear memory.  
Anxiety and depressive phenotypes 
Cacna1c+/- mice have shown decreased depressive-related phenotypes as assessed by the 
tail suspension test45 at 5-7 days following a chronic stress. Cacna1c heterozygosity has 
also been associated with protection against depressive-like phenotypes in the forced swim, 
sucrose preference  and tail suspension tests44,52,53. However, Cacna1c+/- deletion during 
development increases susceptibility to chronic social defeat stress53. In addition, a gene x 
environment human study revealed that SNPs in CACNA1C interact with trauma to predict 
depressive symptoms53, suggesting that depressive-phenotypes may be subject to 
environment factors interacting with CACNA1C.  
Dao et al (2011) reported increased anxiety-related phenotypes in female Cacna1c+/- mice 
only44. Increased anxiety-like phenotypes in males has been reported in Cacna1c+/- mice in 
an annex test42, dark-light box53 and in the open field49 however these findings are not 
consistent across all models40,45. The TS2-neo model has not been associated with 
alterations in anxiety42,43.  
The association between Cav1.2 and anxiety is still not fully understood. However the 
current literature seems to suggest that Cacan1c heterozygosity may result in increased 
anxiety and this effect may be stronger in females. 
Cognition 
Elements of cognitive dysfunction, such as working memory, are common in psychiatric 
disorders and may represent core features of these conditions59. The SNP rs1006737 was 
associated with increased prefrontal activity during executive cognition in healthy humans60 
and impaired logical memory performance14 in those with schizophrenia. SNP rs2007044 
was also associated with poor working memory in schizophrenia patients, potentially through 
decreased prefrontal cortex connectivity to other cortical regions61. 
No significant differences were seen between TS2-neo mice and wild-types in the procedural 
T-maze43, however increased preservative behaviour was observed in the Y maze42. 
Elements of spatial memory have been shown to be affected in Cacna1c-/- conditional 
forebrain knockout mice40,47,50. In the Morris water maze knockout mice could learn the 
spatial task correctly46,47, but they display spatial memory impairments when tested 30 days 
later47. In a neuronal specific Cacna1c knockdown, mice could successful learn a simple 
Morris water maze but had profound deficits in the acquisition of spatial learning within a 
more complex maze when visual cues around the room were limited50. Impairments in a 
water maze spatial-discrimination task have also been reported40.   
These findings have implications for understanding how genetic variants can have an impact 
on underlying cognitive impairments in psychiatric disorders, however more research is 
needed to clarify the primary domains affected. It will also be important to test animal models 
on tasks with a high degree of translational potential, such as rodent analogues of human 
touchscreen tasks, in order to facilitate future integrative research and drug development.   
Neurogenesis 
Cav1.2 may be required for more complex cognitive behaviours such as limited cued Morris 
water mazes where allocentric spatial representations are required. Data has shown that 
adult hippocampal neurogenesis is required for formation of complex forms of spatial 
representations but not simple62, mirroring results seen in cognitive tasks following Cav1.2 
knockdown. This suggests a possible deficit in adult hippocampus may be responsible for 
elements of behaviour dysfunction in these models. 
Psychiatric disorders, and in particular mood disorders, have been linked to alterations in 
adult neurogenesis63. In rodents and humans, neurogenic niches have been found in the 
ventricular-subventricular zone in the lateral ventricles and the subgranular zone (SGZ) of 
the dentate gyrus (DG) in the hippocampus64. These neurogenic cells of the hippocampus 
have been commonly associated with psychiatric and affective disorders63 although this is 
still controversial in the current literature. Adult hippocampal neurogenesis is a complex 
multistep process that is necessary for the generation of new neurons from neural stem cells 
(NSCs). A range of psychotropic medications have been associated with increasing 
neurogenesis in rodent models (including SSRIs, selective SNRIs and tricyclic 
antidepressants)65. There is also increasingly evidence that hippocampal neurogenesis 
contributes to some forms of hippocampus-dependent learning and memory66. There are 
many factors regulating this process: environmental cues, growth factors such as BDNF, 
glucocorticoids and neurotransmitters63. As the literature suggests that stress may interact 
with CACNA1C to cause depressive symptoms, and CACNA1C is known to mediate BDNF 
production, it may be hypothesised that Cav1.2 has a role in neurogenesis, through 
interacting with stress or BDNF.   
LTCCs have been shown to regulate the conversion of adult hippocampal neural precursors 
to immature neurones in a bidirectional manner67. This agrees with findings in genetic 
models; Cacna1c -/- deletions in the forebrain and neurones both show decreases in 
immature neurons (Table 3). In the forebrain-Cav1.2 knockout, this was attributed to 
increased cell death of young neurons, correlated with decreased BDNF levels51. However, 
in a pan-neuronal Cacna1c deletion marked decreases in cell proliferation were seen which 
is likely to be the cause of decreased numbers of immature neurons50. Völkening et al (2017) 
deleted Cacna1c on Type 1 cells and reported decreased proliferation and immature neuron 
production68 (Table 3). These mice also showed deficits in a pattern separation paradigm – a 
type of learning thought to require intact hippocampal neurogenesis68.  
We have used a novel Cacna1c heterozygote (Cacna1c+/-) rat model to investigate if these 
findings could be replicated in another rodent species69. We show a marked decrease in 
cells incorporating 5-bromo-2-deoxyuridine (BrdU)– a nucleotide analogue that marks 
dividing cells- suggesting that proliferation is significantly decreased in the SGZ in this 
model, confirming a key role for Cacna1c in neurogenesis across species. However, we do 
not see any difference in the number of immature neurons, contrasting with the findings in 
the mouse models (Table 3, Figure 1). This may be due to compensatory mechanisms such 
as decreased apoptosis resulting in increased cell survival. Further studies assessing long 
term survival, over following the proliferation, survival, differentiation and integration of newly 
born neurons following BrdU incorporation, would give valuable insight into the functional 
consequences of Cacna1c knockdown on psychology and behaviour related to this process.  
Conclusions 
Associations of psychiatric disorders with the CACNA1C locus has been one of the most 
robust findings from genetic studies in mental health. This has led to the investigation of a 
number of animal models of genetic variation in Cacna1c to study potential risk pathways. 
These models have yielded some clues as to functional impacts – including potential 
alterations in motor behaviours, social interactions as well as increased anxiety and 
preservative behaviour. Interestingly, there may also be a subtle anti-depressive effect of a 
reduced gene dosage of Cacna1c, although interactions with stress may alter this 
phenotype.  
Cav1.2 also appears to play an essential role in elements of hippocampal neuron production, 
suggesting that the alterations seen in neurogenesis in rodent models have also play a part 
in other phenotypes seen. This is of interest as disruptions in SGZ neurogenesis have been 
associated with both psychiatric disorders and treatment response. However, more work is 
needed to determine if this, in fact, a causative effect. 
There are, of course, limitations to the work so far. The majority of the Cacna1c+/- models 
have focused on reduced gene dosage, whereas some of the genetic literature suggests that 
both loss and gain-of-function phenotype may be relevant to disease. Additionally, it is 
important to note that there is an imprecise relationship between rodent behavioural tests 
and human psychiatric disorders. Further studies using translational tasks and assessments 
in both animal models and human subjects with specific genetic variants in CACNA1C will 
be needed to build up the knowledge required for potential therapeutic targeting of LTCCs 
and associated pathways in psychiatric disorders.  
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 Figure Legends 
Figure 1: Cacna1c+/- rats show decreased BrdU, a marker of cell proliferation, in both 
suprapyramidal and infrapyramidal blades of the dentate gyrus (F=11.9133, p =0.0043, One-
way ANOVA). There are no differences in doublecortin positive cells between Cacna1c+/- 
rats and wild-type littermates. Bars represent normalised mean per mm2 +/- SEM, 
n=8/genotype, all males.  
Figure 2: Representative immunofluorescent image of BrdU+ cells (green) and DCX+ cells 
in the dentate gyrus of the hippocampus.  
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Supplementary Material 
 
Materials and Methods 
 
Animals 
 
The Cacna1c+/- rat model was obtained from Sage Research Labs on a Sprague Dawley 
background (TGRA6930, Sage Research Labs, Pennsylvania, USA). Sixteen rats, 8 
Cacna1c+/- rats and 8 wild-type littermates were housed in mixed genotype groups of 2-4 
with ad libitum access to food and water. All animals were handled and tail-marked prior to 
experiments proceeding. Cacna1c+/- animals were indistinguishable from wild-type 
littermates in weight, development and general health. On day of experimentation rats were 
administrated with a single intraperitoneal injection of 50mg/kg BrdU in 0.1 M phosphate 
buffered saline (PBS). 6 hours following BrdU injection rats were euthanised via 
intraperitoneal injection of Euthatal (200mg/ml) and transcardially perfused with PBS, 
followed by 4% paraformaldehyde (PFA). Brains were cryoprotected in 30% sucrose prior to 
sectioning.  
 
Fluorescence immunohistochemistry  
Brains were sectioned using a cryostat (Leica Microsystems CM1860UV) to produce 40µm 
coronal sections spanning the hippocampus (Bregma -2.04mm to -4.68mm), and transferred 
to PBS. To unmask BrdU, sections were first incubated at 37°C for 30 minutes in 2M HCl. 
Sections were thoroughly washed and blocked using 1% Triton-X and 10% donkey serum in 
PBS for 2 hours at room temperature. Primary antibodies were diluted in 0.1% Triton-X and 
0.2% donkey serum in PBS to appropriate concentrations (BrdU: 1:500 (Roche), 
doublecortin: 1:100 (SC8066 - Santa-Cruz)) and allowed to bind sections overnight at 4°C. 
Sections were washed in 0.1 M PBS at least three times and incubated with donkey anti-
goat Alexa 647 and donkey anti-rat Alexa 555 (1:1000) for 2 hours at room temperature in 
the dark. Sections were washed with 0.1 M PBS and incubated for ten minutes in the dark 
with DAPI counterstaining (50ug/ml) for nuclei staining. Sections were washed twice more in 
0.1 M PBS before being mounted on standard microscopy slides using Mowiol aqueous 
mounting medium and standard cover slips. Sections were imaged using an epifluorescent 
microscope (Leica DM6000B Leica Appliation Suite Advanced Flurosecence 3.0.0 build 
8134 software, Leica Microsystems). For every animal, one in seven sections through the 
hippocampus were stained to be counted. Immunopositive cells were quantified through 
visual counting, giving a cell count per mm2. Cell counts were checked for normality and 
homogeneity of variances and transformed in appropriate. One-way ANOVAs were used to 
compare counts between genotypes.  
 
Table 1: Summary of published association studies of SNPs within CACNA1C with 
psychiatric/neurodevelopmental disorders (BPD = bipolar disorder, SCZ = schizophrenia, 
MDD = major depressive disorder, ADHD = attention deficit hyperactivity disorder) 
 
SNP Disorder Risk allele Main references 
rs1006737 BPD A Ferreira et al, 20082 
Sklar et al, 20081 
Green et al, 20133 
Gonzalez et al, 20134 
Liu et al, 20115 
Ruderfer et al, 20146 
Lett et al, 20117 
SCZ A Green et al, 20108 
Nyegaard et al, 20109 
He et al, 201410 
Ivorra et al, 201411 
Guan et al, 201412 
Zheng et al, 201413 
Hori et al, 201214 
Ruderfer et al, 20146 
Autism G Zhao et al, 201515 
MDD A Liu et al, 20115 
Green et al, 20108 
Wray et al, 201016 
Casamassima et al, 201017 
rs4765905 SCZ A Hamshere et al, 201318 
Takahashi et al, 201519 
Autism G Zhao et al, 201515 
rs4765913 BPD A Ripke et al, 201420 
Muhlesisen et al, 201421 
SCZ A Ripke et al, 201420 
MDD A Ripke et al, 201320 
rs1024582 BPD, SCZ, 
ADHD, 
MDD, 
Autism 
A Cross-Disorder Group of the 
Psychiatric Genomics 
Consortium, 201322 
rs2007044 SCZ A Ripke et al, 201320 
Pardiñas et al, 201823 
rs7297582 BPD T Liu et al, 20115 
MDD T Liu et al, 20115 
rs12898315 SCZ A Pardiñas et al, 201823 
rs10744560 BPD T Stahl et al, 201824 
Table 1: Overview of the currently studied mouse models of Cacna1c dysfunction and their 
associated psychiatric and mood phenotypes 
 
Study Model Phenotype 
Bader et al, 201142 TS2_neo+/- ↓ novelty induced locomotion  
↓ sociability  
↑ cued and contextual fear memory 
↓ extinction of fear memory 
↑ preservation in Y maze 
Kabitzke et al, 201843 TS2_neo+/- ↓ social-induced locomotion 
↓ sociability 
 
Dao et al, 201044 Cacna1c+/- ↓ exploratory activity in females 
↓ locomotion in females 
↓ depressive phenotype 
↑ anxiety in females 
Bader et al, 201142 Cacna1c+/-  ↓ basal and novelty induced locomotion 
↑ anxiety  
 
Bavley et al, 201745 Cacna1c+/- ↓ depressive phenotype 
Moosmang et al, 
200540 
Cacna1c-/- (forebrain 
only) 
↓ spatial discrimination  
McKinney et al, 
200846 
Cacna1c-/- (forebrain 
excitatory neurons 
only) 
No effect on contextual fear memory 
White et al, 200847 Cacna1c-/- (forebrain 
only) 
↓ long-term spatial memory 
Langwieser et 
al, 201048 
Cacna1c-/- (CNS only) No effect on cued fear memory 
Lee et al, 201249 Cacna1c-/- (prefrontal 
cortex only) 
↑ anxiety 
Temme et al, 201650 Cacna1c-/- (neurons 
only) 
↓ context discrimination  
↓ spatial memory (complex task) 
↓ neurogenesis 
Lee et al, 201651 Cacna1c-/- (forebrain 
only) 
↓ neurogenesis 
Kabir et al, 201752 Cacna1c-/- (prefrontal 
cortex only) 
↓ depressive phenotype 
Dedic et al, 201853 Cacna1c+/- (excitatory 
neurons only) 
↓ sociability 
↓ depressive phenotypes 
↑ susceptibility to chronic social defeat 
stress 
↑ anxiety 


